Blog Layout

Tax Tactics: Winter 2016

December 14, 2016

Is It Time to Revisit the Research Credit?

If your business hasn’t been claiming the research credit (often referred to as the “research and development,” “R&D” or “research and experimentation” credit), now may be a good time to revisit this valuable tax break. Last year’s Protecting Americans from Tax Hikes (PATH) Act made the credit permanent after 34 years of being temporary, including numerous extensions, and expanded the credit’s benefits to certain start-ups and other small businesses that were unable to take advantage of it in past years.

A quick overview

The research credit is complex, but in a nutshell it allows businesses to claim a nonrefundable credit equal to 20% of the amount by which their qualified research expenditures (QREs) exceed a base period amount. You can carry back unused credits one year and forward up to 20 years. Be aware that the research has to be conducted within the United States (including Puerto Rico and U.S. possessions).

To determine the base period amount, calculate your ratio of QREs to gross receipts from 1984 to 1988 and apply it to your average gross receipts for the previous four tax years. (The base period amount cannot be less than 50% of your current-year QREs, however.) There are alternative methods of calculating the credit for companies that didn’t exist from 1984 to 1988, lacked sufficient QREs or gross receipts during that period, or otherwise have trouble qualifying for the traditional research credit. These include an alternative incremental credit (AIC) and a simplified credit. Whichever method you use, the net cash benefit of research credits typically is 6.5% of QREs.

Many companies overlook the research credit because they think it’s limited to companies that conduct laboratory research, such as biotech, pharmaceutical or high-tech firms. But the credit is available to any company that invests in developing new or improved products or processes, including retail and consumer product companies and even service providers. To qualify, research activities must:

  • Strive to discover information that’s technological in nature,
  • Relate to a new or improved “business component,” such as a product, process, computer software, technique, formula or invention,
  • Be designed to eliminate uncertainty concerning the development or improvement of a business component, and
  • Be part of a “process of experimentation.”

Generally, QREs include supplies, W-2 wages for employees conducting research, and 65% of consultants’ fees.

New benefits for smaller businesses

Before the PATH Act, it was challenging for smaller companies to take advantage of research credits, even if they conducted a significant amount of qualified research activities. One obstacle, particularly for partnerships and S corporations, was the alternative minimum tax (AMT), which often restricted or even eliminated the owners’ ability to use the research credit. The PATH Act solves this problem by allowing businesses with average gross receipts of $50 million or less during the previous three years to claim the credit against the AMT, beginning this year.

Historically, start-up businesses (companies in operation for less than five years with less than $5 million in gross receipts) haven’t been able to take advantage of research credits because they have little or no tax liability. To allow start-ups to enjoy the benefits of the credit without having to wait until they start generating taxable income, the PATH Act permits them to claim the credit against up to $250,000 in employer-paid FICA taxes.

Get the credit you deserve

R&D benefits many businesses and should benefit the company doing it. If your company commits resources to developing new or improved products or processes, it pays to consult your tax advisor to see if you qualify for research credits.

© 2016

This material is generic in nature. Before relying on the material in any important matter, users should note date of publication and carefully evaluate its accuracy, currency, completeness, and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.

Share Post:

By Katrina Arona February 19, 2025
The Corporate Transparency Act (CTA) which took effect on January 1, 2024 required "reporting companies" in the United States to disclose information about their beneficial owners to the Treasury Department's Financial Crimes Enforcement Network (FinCEN). In May 2024, a lawsuit was filed claiming that Congress exceeded its authority under the Constitution in passing the CTA. Background: December 3, 2024 in the Texas Top Cop Shop, Inc., et al. v. Merrick Garland, Attorney General of the United States, et al., Judge Amos Mazzant of the United States District Court (Eastern District of Texas/Sherman Division) issued a preliminary nationwide injunction barring the enforcement of the Corporate Transparency Act (CTA). December 23, 2024 the Nationwide Injunction is lifted and filing deadlines are reinstated. Financial Crimes Enforcement Network of the U.S. Department of Treasury (FinCEN) may again enforce the CTA. FinCEN has not extended any filing deadlines. Therefore, all reporting companies should file immediately any beneficial ownership information reports (BOIRs) that were already due, and reporting companies formed prior to 2024 should file their BOIRs by January 13, 2025 (extended from January 1, 2025). December 27, 2024 the federal appeals court on Thursday reinstated a nationwide injuction halting enforcement of beneficial ownership information (BOI) reporting requirements, reversing an order the same court issued earlier this week. FinCEN issued an updated alert on its BOI information page , saying that companies can voluntarily submit BOI reports. February 7, 2025 FinCEN will consider changes to the BOI reporting requirements if a court grants the government's request for a stay of a nationwide injunction in a Texas case, according to a motion filed Wednesday, February 5th. If the stay is granted, FinCEN will extend BOI filing deadlines for 30 days, the government said in its filing in Samantha Smith and Robert Means v. U.S. Department of the Treasury, No. 6:24-CV-336 (E.D. Texas 1/7/25). BOI reporting is currently voluntary, pending further legal developments. Businesses and stakeholders should stay alert for additional updates as the situation evolves. Current Status: February 18, 2025 A federal court lifted the last remaining nationwide injunction stopping BOI reporting requirements. FinCEN which enforces BOI requirements under the CTA said it would extend filing deadline for initial, updated, and/or corrected BOI reports to March 21. However, reporting companies that were previously given a deadline later than March 21 may file their initial BOI report by that later deadline. Resources for consideration: March 21 BOI reporting deadline set; further delay possible BOI Injunction Lifted FinCEN BOI Center
By Katrina Arona February 12, 2025
February 7, 2025 FinCEN will consider changes to the BOI reporting requirements if a court grants the government's request for a stay of a nationwide injunction in a Texas case, according to a motion filed Wednesday, February 5th. If the stay is granted, FinCEN will extend BOI filing deadlines for 30 days, the government said in its filing in Samantha Smith and Robert Means v. U.S. Department of the Treasury, No. 6:24-CV-336 (E.D. Texas 1/7/25). BOI reporting is currently voluntary, pending further legal developments. Businesses and stakeholders should stay alert for additional updates as the situation evolves
By Katrina Arona February 10, 2025
Some nonprofit executives try to control as much as they can. But micromanagement isn’t conducive to creating an effective team.
Show More
Share by: